CFCF

      2011 E-Update Number 18
Donate
In this Issue
Spreading the Word on Neuroendocrine Cancer
Lauren Blogs about the FDA
Cycle for Survival 2012
Advertisement from our Sponsor
NVS logo
CFCF is pleased to announce that this E-Update is supported by Novartis Pharmaceuticals Corporation
Follow us on Twitter!

 

Like us on Facebook!

 

Visit us on YouTube! 

 

Jim Rich  
 Jim Rich
(submitted 10/11/11)
  
CFCF is honored to present Survivor Stories. They reflect remarkable courage and determination. Thank you to our Survivors for sharing their courage and words of hope with other patients.

Read our newest survivor stories: 
Kayla,
Sarah M., Christine Laking

Join Us for a Cure
seatle to portland 08

Make a difference and get involved with CFCF!  Unite, meet fellow members of the carcinoid community, and spread awareness at upcoming CFCF events!
Give hope and a future to  neuroendocrine tumor patients: donate to CFCF where 100% of all individual donations go to carcinoid and related neuroendocrine tumor research. CFCF is a 501(c)(3) organization-all contributions are tax-deductible.  We want our donors to know that we are allocating their donations responsibly and wisely to achieve a carcinoid cure as quickly as possible. 


To learn more, view CFCF's:
Audited Financial Statements
IRS Form 990

Caring for Carcinoid Foundation
198 Tremont Street, Box 456
Boston, MA 02116
617.948.2514
www.caringforcarcinoid.org
BBB Accredited Charity
CFCF meets all 20 Wise Giving Alliance standards for charity accountability established by the Better Business Bureau. Click here to check out the CFCF Wise Giving Report.
Spreading the Word on Neuroendocrine Cancer

Like In honor of Worldwide NET Cancer Awareness Day, the Caring for Carcinoid Foundation is reaching out to the internet community to spread the word about carcinoid and related neuroendocrine cancers.

 

Our goal is to unite the neuroendocrine cancer community by reaching 2,000 fans by November 10. Please ask your friends to visit us at http://www.facebook.com/CaringForCarcinoidFoundation and to click the "like" button at the top of the page.

 

With your help, we can increase visibility of neuroendocrine cancers and move toward a cure!  

Lauren Blogs About the Need for a Strong FDA

Lauren ErbThe United States Food and Drug Administration (FDA) is responsible for approving and regulating therapies for patients for rare diseases. But how does the FDA do that? What processes are involved?

 

CFCF Executive Director Lauren Erb sheds some light on the FDA and two organizations working to improve its efficacy in her latest blog. To learn more about advocating on behalf of carcinoid and related neuroendocrine cancer patients, visit the Advocate for Change section of CFCF's website. 

Cycle for Survival With Dr. Diane Reidy-Lagunes

Dr. Diane Reidy LagunesThis February, thousands of participants across the United States will hop on stationary bikes to raise vitally-needed funds for rare cancer research. CFCF has entered a team in the "Cycle for Survival" for several years now to support the research of Dr. Diane Reidy-Lagunes at Memorial Sloan Kettering Cancer Center in New York City.

 

This year is a special treat, as Dr. Reidy-Lagunes herself will be pedaling along with Team CFCF! To learn about how you can get involved, click here.   

Advertisement from our Sponsor

 iWalk for Carcinoid  FDA MedWatch Full Prescribing Information